Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?

Author： Bruce David   Tan Peng H  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1413-1434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 573-578

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor 1, a Therapeutic Target in Cancer, Inflammation and Other Disorders

By  

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2890-2898

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 1000-1017

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation

By Ramakrishnan S.   Anand Vidhu   Roy Sabita  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 142-160

Springer Publishing Company

Access to resources Recommend Favorite

NOTCH Signaling as a Novel Cancer Therapeutic Target

By  

Current Cancer Drug Targets, Vol. 6, Iss. 4, 2006-06 ,pp. : 313-323

Bentham Science Publishers

Access to resources Recommend Favorite